Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Scilex Pharmaceuticals Inc. See All Filings	D	2016-05-17 00:00:00 UTC
Amount To Be Raised $479,930 Associated Brokers / Dealers Mid Atlantic Medical Association, LLC CIK Number 0001603542 Filed Document 0000905718-16-001448 Exclusions or Exemptions 506b Accepted Date 2016-05-17 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Scilex Pharmaceuticals Inc. See All Filings	D	2015-03-31 00:00:00 UTC
Amount To Be Raised $2,025,274 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001603542 Filed Document 0000905718-15-000328 Exclusions or Exemptions 506b Accepted Date 2015-03-31 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Scilex Pharmaceuticals Inc. See All Filings	D	2014-08-07 00:00:00 UTC
Amount To Be Raised $5,001,700 Associated Brokers / Dealers N/A CIK Number 0001603542 Filed Document 0000905718-14-000496 Exclusions or Exemptions 506b Accepted Date 2014-08-07 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Scilex Pharmaceuticals Inc. See All Filings	D/A	2014-08-04 00:00:00 UTC
Amount To Be Raised $5,250,000 Associated Brokers / Dealers NONE, NONE, and NONE CIK Number 0001603542 Filed Document 0000905718-14-000492 Exclusions or Exemptions 506b Accepted Date 2014-08-04 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Scilex Pharmaceuticals, Inc See All Filings	D	2014-03-24 00:00:00 UTC
Amount To Be Raised $5,250,000 Associated Brokers / Dealers NONE CIK Number 0001603542 Filed Document 0001144204-14-017812 Exclusions or Exemptions 506b Accepted Date 2014-03-24 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity